By Dr. Tomislav Meštrović, MD, Ph.D. A new study published on the preprint server medRxiv* by a research group from the U.S. and Germany indicates that a novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) induces functional and proinflammatory T cell responses in almost all participants – marking another landmark achievement for this promising vaccine...
KING’S COLLEGE LONDON Cancer patients diagnosed more than 24 months ago are more likely to have a severe COVID-19 infection, research has found. Cancer patients of Asian ethnicity or who were receiving palliative treatment for cancer were also at a higher risk of death from COVID-19. The research published today in Frontiers in Oncology by...
by Marilynn Marchione In this Friday, June 12, 2020 file photo, a woman has blood drawn for COVID-19 antibody testing in Dearborn, Mich. Research published on Tuesday, July 21, 2020 suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness. (AP Photo/Paul...
by Columbia University Irving Medical Center Cryo-EM reconstructions show how two different antibodies (blue) bind to the spike protein of the SARS-CoV-2 virus. Credit: David Ho / Columbia University Irving Medical Center Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in...
Reviewed by James Ives, M.Psych. (Editor) Researchers from the Department of Computer Architecture and Technology at the University of Seville’s School of Computer Engineering (ETSII) are working on a system that uses X-ray images of patients’ lungs to help diagnose COVID-19. This system uses deep learning to train a neural network model that can distinguish...
An analysis of COVID-19 testing in the Baltimore-Washington metropolitan area of the United States found that Latinx people were around three times as likely to test positive, compared with any other ethnic or racial group. All data and statistics are based on publicly available data at the time of publication. Some information may be out...
By HARRIET ALEXANDER FOR DAILYMAIL.COM Cholesterol-lowering drug Fenofibrate (Tricor) is providing a glimmer of hope Scientists in New York and Jerusalem believe the drug could help treat COVID The drug could reduce symptoms so that COVID-19 is no worse than a common cold, the study found Two scientists researching a potential treatment for coronavirus believe...
RADIOLOGICAL SOCIETY OF NORTH AMERICA OAK BROOK, Ill. (July 16, 2020) – COVID-19 is associated with life-threatening blood clots in the arteries of the legs, according to a study published in Radiology. Researchers said COVID-19 patients with symptoms of inadequate blood supply to the lower extremities tend to have larger clots and a significantly higher...
As COVID-19 burns through Texas, districts and health departments across the state are wrestling with how to provide childcare and schooling to the state’s 7 million-plus children. Jerri Barker, who runs a daycare in Waco, has watched warily as other facilities in the area began to report cases of COVID-19 in recent weeks. First, a...
By MARLENE LENTHANG FOR DAILYMAIL.COM he military’s number of coronavirus cases is rising at twice the national rate seeing a 33% spike from July 1 to 10 The national case growth rate was 16% for that same time period Since July 1 over 4,100 service members have tested positive for coronavirus In total there are...
